Global Device Approvals, Weekly Snapshot: Roche’s Breast-Cancer Companion Diagnostic; Nemara’s Eye-Dropper
Executive Summary
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, US FDA approved Roche’s Ventana PD-L1 assay as the first companion diagnostic to aid in identifying triple-negative breast cancer, and Nemera announced that its Novelia Cosopt iMulti eye-dropper will soon be available in 29 European countries.